My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 84

    1.

    Evaluation of ITX 5061, a scavenger receptor B1 antagonist: resistance selection and activity in combination with other hepatitis C virus antivirals.

    Zhu H, Wong-Staal F, Lee H, Syder A, McKelvy J, Schooley RT, Wyles DL.

    J Infect Dis. 2012 Feb;205(4):656-62.

    PMID:
    22279172
    [PubMed - indexed for MEDLINE]

    Related citations

    2.

    Genetic diversity of recently acquired and prevalent HIV, hepatitis B virus, and hepatitis C virus infections in US blood donors.

    Delwart E, Slikas E, Stramer SL, Kamel H, Kessler D, Krysztof D, Tobler LH, Carrick DM, Steele W, Todd D, Wright DJ, Kleinman SH, Busch MP; NHLBI-REDS-II Study Group.

    J Infect Dis. 2012 Mar;205(6):875-85. Epub 2012 Jan 31.

    PMID:
    22293432
    [PubMed - indexed for MEDLINE]

    Related citations

    3.

    Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion.

    Raghuraman S, Park H, Osburn WO, Winkelstein E, Edlin BR, Rehermann B.

    J Infect Dis. 2012 Mar;205(5):763-71. Epub 2012 Jan 31.

    PMID:
    22293431
    [PubMed - indexed for MEDLINE]

    Related citations

    4.

    Effect of age on the incidence of acute hepatitis B after 25 years of a universal newborn hepatitis B immunization program in Taiwan.

    Su WJ, Liu CC, Liu DP, Chen SF, Huang JJ, Chan TC, Chang MH.

    J Infect Dis. 2012 Mar;205(5):757-62. Epub 2012 Jan 19.

    PMID:
    22262790
    [PubMed - indexed for MEDLINE]

    Related citations

    5.

    More lessons from the Taiwanese hepatitis B virus vaccine program.

    Schwarz KB.

    J Infect Dis. 2012 Mar;205(5):702. Epub 2012 Jan 19. No abstract available.

    PMID:
    22262789
    [PubMed - indexed for MEDLINE]

    Related citations

    6.

    Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia in HIV/HCV-coinfected patients with all HCV genotypes.

    Naggie S, Rallon NI, Benito JM, Morello J, Rodriguez-Novoa S, Clark PJ, Thompson AJ, Shianna KV, Vispo E, McHutchison JG, Goldstein DB, Soriano V.

    J Infect Dis. 2012 Feb;205(3):376-83. Epub 2011 Dec 9.

    PMID:
    22158703
    [PubMed - indexed for MEDLINE]

    Related citations

    7.

    Preventing deaths in persons with HIV/hepatitis B virus coinfection: a call to accelerate prevention and treatment efforts.

    Peters PJ, Marston BJ.

    J Infect Dis. 2012 Jan 15;205(2):166-8. Epub 2011 Dec 5. No abstract available.

    PMID:
    22147795
    [PubMed - indexed for MEDLINE]

    Related citations

    8.

    Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters.

    Chun HM, Roediger MP, Hullsiek KH, Thio CL, Agan BK, Bradley WP, Peel SA, Jagodzinski LL, Weintrob AC, Ganesan A, Wortmann G, Crum-Cianflone NF, Maguire JD, Landrum ML; Infectious Disease Clinical Research Program HIV Working Group.

    J Infect Dis. 2012 Jan 15;205(2):185-93. Epub 2011 Dec 5.

    PMID:
    22147794
    [PubMed - indexed for MEDLINE]

    Related citations

    9.

    Toward the establishment of a prediction system for the personalized treatment of chronic hepatitis C.

    Ochi H, Hayes CN, Abe H, Hayashida Y, Uchiyama T, Kamatani N, Nakamura Y, Chayama K.

    J Infect Dis. 2012 Jan 15;205(2):204-10. Epub 2011 Nov 28.

    PMID:
    22124128
    [PubMed - indexed for MEDLINE]

    Related citations

    10.

    Management of chronic hepatitis B e antigen-negative disease: another step forward.

    Lau GK, Wang FS.

    J Infect Dis. 2012 Jan;205(1):7-9. Epub 2011 Nov 17. No abstract available.

    PMID:
    22095767
    [PubMed - indexed for MEDLINE]

    Related citations

    11.

    Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters.

    Tseng TC, Liu CJ, Chen CL, Wang CC, Su TH, Kuo SF, Chen PJ, Chen DS, Kao JH.

    J Infect Dis. 2012 Jan;205(1):54-63. Epub 2011 Nov 17.

    PMID:
    22095766
    [PubMed - indexed for MEDLINE]

    Related citations

    12.

    IL28B rs12979860 genotype and spontaneous clearance of hepatitis C virus in a multi-ethnic cohort of injection drug users: evidence for a supra-additive association.

    Shebl FM, Pfeiffer RM, Buckett D, Muchmore B, Chen S, Dotrang M, Prokunina-Olsson L, Edlin BR, O'Brien TR.

    J Infect Dis. 2011 Dec 15;204(12):1843-7. Epub 2011 Oct 19.

    PMID:
    22013224
    [PubMed - indexed for MEDLINE]

    Related citations

    13.

    Agent, host, and environment: hepatitis C virus in people who inject drugs.

    Hagan H.

    J Infect Dis. 2011 Dec 15;204(12):1819-21. Epub 2011 Oct 19. No abstract available.

    PMID:
    22013223
    [PubMed - indexed for MEDLINE]

    Related citations

    14.

    Hepatitis C transmission in injection drug users: could swabs be the main culprit?

    Thibault V, Bara JL, Nefau T, Duplessy-Garson C.

    J Infect Dis. 2011 Dec 15;204(12):1839-42. Epub 2011 Oct 19.

    PMID:
    22013222
    [PubMed - indexed for MEDLINE]

    Related citations

    15.

    Inactivation and survival of hepatitis C virus on inanimate surfaces.

    Doerrbecker J, Friesland M, Ciesek S, Erichsen TJ, Mateu-Gelabert P, Steinmann J, Steinmann J, Pietschmann T, Steinmann E.

    J Infect Dis. 2011 Dec 15;204(12):1830-8. Epub 2011 Oct 19.

    PMID:
    22013220
    [PubMed - indexed for MEDLINE]

    Related citations

    16.

    Neutralizing antibodies to hepatitis C virus in perinatally infected children followed up prospectively.

    Meunier JC, Bukh J, Diaz G, Tovo PA, Casadei AM, Quinti I, Iorio R, Emerson S, Purcell RH, Farci P.

    J Infect Dis. 2011 Dec;204(11):1741-5. Epub 2011 Oct 17.

    PMID:
    22006993
    [PubMed - indexed for MEDLINE]

    Related citations

    17.

    High plasma interleukin-18 levels mark the acute phase of hepatitis C virus infection.

    Chattergoon MA, Levine JS, Latanich R, Osburn WO, Thomas DL, Cox AL.

    J Infect Dis. 2011 Dec;204(11):1730-40. Epub 2011 Oct 7.

    PMID:
    21984735
    [PubMed - indexed for MEDLINE]

    Related citations

    18.

    Enhanced replication of hepatitis B virus with frameshift in the precore region found in fulminant hepatitis patients.

    Inoue J, Ueno Y, Wakui Y, Fukushima K, Kondo Y, Kakazu E, Ninomiya M, Niitsuma H, Shimosegawa T.

    J Infect Dis. 2011 Oct 1;204(7):1017-25.

    PMID:
    21881116
    [PubMed - indexed for MEDLINE]

    Related citations

    19.

    Vaccine-induced cross-genotype reactive neutralizing antibodies against hepatitis C virus.

    Meunier JC, Gottwein JM, Houghton M, Russell RS, Emerson SU, Bukh J, Purcell RH.

    J Infect Dis. 2011 Oct 15;204(8):1186-90.

    PMID:
    21917891
    [PubMed - indexed for MEDLINE]

    Related citations

    20.

    Altered expression of SHIP, a Toll-like receptor pathway inhibitor, is associated with the severity of liver fibrosis in chronic hepatitis C virus infection.

    Katsounas A, Trippler M, Kottilil S, Lempicki RA, Gerken G, Schlaak JF.

    J Infect Dis. 2011 Oct 15;204(8):1181-5.

    PMID:
    21917890
    [PubMed - indexed for MEDLINE]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk